Stay updated on MRTX849 Pharmacokinetics & Safety Clinical Trial
Sign up to get notified when there's something new on the MRTX849 Pharmacokinetics & Safety Clinical Trial page.

Latest updates to the MRTX849 Pharmacokinetics & Safety Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe ClinicalTrials.gov record now presents details of the Phase 1 MRTX849 study in Chinese patients, including eligibility criteria, study locations, treatment plan, outcomes, and record dates.SummaryDifference56%

- Check16 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0 while the page continues to show a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check23 days agoChange DetectedA notice appears above the site navigation announcing NIH website transition updates and stating that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence.”SummaryDifference1%

- Check30 days agoChange DetectedThe footer’s site revision identifier advances from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check37 days agoChange DetectedThe footer revision changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check58 days agoChange DetectedThe page now shows a 403 Forbidden error indicating restricted access to the study record.SummaryDifference19%

Stay in the know with updates to MRTX849 Pharmacokinetics & Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MRTX849 Pharmacokinetics & Safety Clinical Trial page.